Focus On Medtech Sectors With Healthy Growth: Wearable Diagnostics

Posted by Life Science Intelligence on Sep 26, 2019 6:24:21 PM

With a growing focus on the global need for healthcare that is affordable and accessible to anyone, anywhere in the world, comes a look at technologies that are designed to lessen the gap between quality care and individuals outside of developed cities and countries.

Read More

Topics: Insider, Startup, Strategics, Medtech, Medtech Venture Capital

Diagnostic Imaging: Innovators Challenging Huge Markets

Posted by Life Science Intelligence on Aug 20, 2019 6:30:50 AM

Diagnostic imaging devices are essential throughout the continuum of healthcare. From an initial diagnosis and patient evaluation, to guiding procedures, and ultimately following-up and monitoring the effectiveness of interventions post-op - the versatility of diagnostic imaging devices has made them essential to nearly every branch of medicine. Diagnostic imaging encompasses a number of different modalities, such as computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and X-ray. High-quality diagnostic imaging devices are critical to assisting healthcare providers in the decision-making and treatment processes.

Read More

Topics: Startup, Strategics, Medtech, Medtech Venture Capital

The Next Medtech Unicorn - AI, Robotics, Advanced Imaging, Other?

Posted by Life Science Intelligence on Aug 12, 2019 7:50:59 AM

According to recently shared research from CB Insights, there are over 30 healthcare startups valued at over $1B. The majority of these “unicorns” are developing solutions for the rapidly growing digital healthcare market. Artificial intelligence (AI), cloud-based solutions, big data, and other technological innovations are all being explored and implemented in new ways to improve the healthcare industry.

Read More

Topics: Startup, Strategics, Medtech, Medtech Venture Capital

Beating Cancer: Medtech Startups to Share Plans with Investors and Strategic Partners at Emerging Medtech Summit

Posted by Life Science Intelligence on Aug 6, 2019 7:25:27 AM

Early-stage medtech companies Quantason, CivaTech Oncology, Navigation Sciences, MagForce and ChemoTech are going after Cancer in big ways.  

Identifying cancer and treating it in its earliest stages is one of the greatest challenges facing our healthcare system. Early detection and treatment of cancer is linked to the best clinical outcomes in terms of overall survival and treatment success. To that end, many pharmaceutical, diagnostic, and medical device developers are committed to addressing the global burden of cancer. Recent statistics from the International Agency for Research on Cancer estimated that there 17 million incident cases of cancer and 9.5 million deaths attributable to cancer globally in 2018. Global forecasts suggest that the burden of cancer will only grow despite current efforts to address the disease. There is still much work to be done if we are to successfully “beat cancer”. While pharmaceuticals, or chemotherapy, often come to mind when people think of how cancer is treated, the reality is that cancer treatment is a complex process that integrates multiple diagnostics and therapeutic options.

Read More

Topics: Startup, Strategics, Medtech, Medtech Venture Capital

Orthopedic Startups are Innovating, Raising Capital and Poised to Challenge a $40B Market

Posted by Life Science Intelligence on Jul 24, 2019 10:52:22 AM

Select innovators Ossio, Greenbone, Embody, Biorez, Carmell Therapeutics, Nanochon, ZKR Ortho, HAPPE Spine will be in the spotlight (and no doubt catching attention from investors and major strategics) at the Emerging Medtech Summit.

Read More

Topics: Startup, Strategics, Medtech, Medtech Venture Capital

60 Emerging Medical Technology Startups Present to Audience of Investors and Strategics as they Aim to Disrupt the $600B Global Medical Device & Diagnostic Market

Posted by Life Science Intelligence on Jun 4, 2019 7:52:17 AM

The Emerging Medtech Summit 2020 will spotlight Sixty (60) of the hottest emerging medtech companies, many of which are raising capital, ripe for M&A, or already planning for an IPO or exit.

Read More

Topics: Startup, Strategics, Medtech, Medtech Venture Capital